Phase I/II study of pentostatin combined with tacrolimus and mini-methotrexate for GVHD [graft-versus-host disease] prevention after matched-unrelated donor blood and marrow transplantation.

Trial Profile

Phase I/II study of pentostatin combined with tacrolimus and mini-methotrexate for GVHD [graft-versus-host disease] prevention after matched-unrelated donor blood and marrow transplantation.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Aug 2012

At a glance

  • Drugs Methotrexate; Pentostatin; Tacrolimus
  • Indications Graft-versus-host disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 06 Aug 2007 Status changed from recruiting to in progress.
    • 25 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top